EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bifurcation study of a tumor-immune system with chemotherapy

Abdelhamid Ajbar iD, Rubayyi T Alqahtani, Khalid Alhumaizi

PLOS One · 03.07.2025 · 20 (7) · e0327304

DOI: 10.1371/journal.pone.0327304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 03.07.2025. Verfasst von Abdelhamid Ajbar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering Department, College of Engineering, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Immune System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the dynamics of cancer cell growth, the interplay between tumor and immune cells, and the efficacy of chemotherapy are pivotal areas of focus in cancer research. In this regard, mathematical modeling can provide significant insights. This study re-examines a classical two-dimensional model of tumor-immune cell interactions where the tumor’s growth rate is assumed to adhere to von Bertalanffy’s model instead of the logistic model. We investigate the model both without chemotherapy and with treatment. The equilibrium points are identified, classified, and their stability analyzed. Our results reveal that the model can demonstrate a broad spectrum of behaviors, including bi-stability and multi-stability as well as regions of stable periodic behavior. We establish analytical conditions for the existence of Hopf points. Furthermore, we assess the impact of model parameters on the various behavior predicted by the model. This mathematical investigation can provide general guidance on treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsImmune SystemHumansModels, BiologicalModels, TheoreticalCell Proliferation

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemical Engineering Department, College of Engineering, King Saud University, Riyadh, Saudi Arabia.
  • Department of Mathematics and Statistics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.

ORCID-Profile: Abdelhamid Ajbar

Förderung

  • Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University

Zitieren

APA

Ajbar, A., Alqahtani, R. T., & Alhumaizi, K. (2025). Bifurcation study of a tumor-immune system with chemotherapy. PLOS One, 20(7), e0327304. https://doi.org/10.1371/journal.pone.0327304

Vancouver

Ajbar A, Alqahtani RT, Alhumaizi K. Bifurcation study of a tumor-immune system with chemotherapy. PLOS One. 2025;20(7):e0327304. doi:10.1371/journal.pone.0327304

BibTeX
@article{Ajbar2025,
  author = {Ajbar, Abdelhamid and Alqahtani, Rubayyi T and Alhumaizi, Khalid},
  title = {Bifurcation study of a tumor-immune system with chemotherapy},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {7},
  pages = {e0327304},
  doi = {10.1371/journal.pone.0327304}
}
Kostenlos starten →